Forbindelse i forskningskvalitet. Kun til laboratoriebrug. Ikke beregnet til brug, indtagelse eller injektion hos mennesker eller dyr. Ingen medicinske påstande fremsættes eller antydes.
Humanin 10mg
Gratis forsendelse på ordrer over €200
- Hvis et produkt ikke svarer til specifikationen på dets offentliggjorte COA, så kontakt os med dit batchnummer: vi undersøger det op mod batchens rapport og erstatter ethvert produkt, der ikke består, uden omkostninger for dig.
- Kontakt os inden for 48 timer efter levering med billeder af den ydre kasse, den indre emballage og eventuelle berørte hætteglas med læselige etiketter. Bekræftet transportskade erstattes uden omkostninger for dig.
3–7 dage til de fleste EU-lande · 10–14 dage til Norden og de baltiske lande
Standardfragt i EU fra 4,99 € (RO) · centrale EU-lande (GLS) 17,99 € · Norden og de baltiske lande 12,99 €–15,99 € · Afsendelse inden for 1–2 hverdage · Gratis fragt over 200,00 € · ingen toldpapirer (EU) · via netværket af fragtfirmaer i EU
200,00 € fra gratis fragt over 200,00 €. Derunder koster standardfragt i EU 17,99 € (GLS, de fleste EU-lande).
Sådan fungerer Paysera og SEPA
- Betal: Send en manuel SEPA-overførsel til den IBAN, vi sender dig på e-mail, eller, hvis muligheden tilbydes i kassen for din adresse, godkend en SEPA-overførsel i din egen bank via Payseras hostede side.
- Vi bekræfter: Paysera giver os besked med det samme, eller vi matcher en manuel overførsel med din ordre, når den modtages (normalt 1 hverdag).
- Vi afsender: Bekræftede ordrer afsendes typisk inden for 1-2 hverdage.
Kortbetalinger tilbydes ikke i øjeblikket. Der er ingen kortindløser tilknyttet denne kasse.
Research-grade Humanin. Class-level specification ≥98%. Lyophilized powder in sealed glass vial. For laboratory research use only. Not for human consumption.
| Antal | Pris pr. stk. | I alt | Besparelse |
|---|---|---|---|
| 1 unit | 80,49 € | 80,49 € | -- |
| 3+ | 76,47 € | 229,40 € | 5% rabat |
| 5+Mest populær | 72,44 € | 362,21 € | 10% rabat |
| 10+ | 68,42 € | 684,17 € | 15% rabat |
Vigtig meddelelse
Dette produkt er kun beregnet til laboratorie- og forskningsbrug. Ikke til human eller veterinær brug. Ved køb bekræfter du, at dette produkt udelukkende vil blive brugt til in vitro-forskningsformål.
På grund af juridiske og regulatoriske krav kan dette produkt ikke sendes til: Italien, Kroatien, Litauen og Slovenien.
Rekonstitution påkrævet
Dette peptid sendes lyofiliseret (tørt pulver) og kræver bakteriostatisk vand til rekonstitution før brug. BAC-vand sælges separat.
Hvornår dette produkt måske ikke passer til din forskning
- ⚠Hvis din forskning kræver materiale i GMP-kvalitet til kliniske anvendelser — peptider i forskningskvalitet er ikke beregnet til klinisk brug.
- ⚠Hvis dit laboratorium mangler korrekt kold opbevaring (-20°C-fryser) — dette peptids stabilitet kan blive forringet ved højere temperaturer.
- ⚠Hvis din studieprotokol kræver FDA-godkendte referencestandarder — kontakt USP eller en udbyder af certificeret referencemateriale.
Der er offentliggjort laboratorierapporter for udvalgte partier. Se hver rapport for resultatet og den angivne metode. Kun til forskningsformål.
Janoshik-rapport offentliggøres, når den er tilgængelig
Afsendelse inden for 1–2 hverdage, levering fra 4,99 € i Rumænien, fra 12,99 € i resten af Europa
Registreret specifikation på klasseniveau; uafhængig Janoshik-rapport på udvalgte partier
Om Humanin 10mg
Humanin is a 21-amino acid peptide encoded not in the nuclear genome but in the mitochondrial 16S rRNA gene -- an unusual origin that has made it the founding member of a class of mitochondria-derived peptides (MDPs). It was originally identified in 2001 by researchers screening for factors that protect neurons from Alzheimer's disease-related cell death. The name reflects this discovery context: a peptide that made cells "more human" by rescuing them from neurodegeneration.
Humanin acts through multiple receptor pathways. It binds the formyl peptide receptor-like 1 (FPRL1/FPR2), the CNTF receptor alpha subunit, and has intracellular targets as well. In Alzheimer's disease cell models, it has been reported to protect neurons from amyloid-beta toxicity, ADDL (amyloid-derived diffusible ligand) toxicity, and oxidative stress. Beyond neuroprotection, preclinical studies report anti-apoptotic, insulin-signalling and anti-inflammatory effects in cell and animal models. Circulating humanin levels have been reported to decline with age, which has made it a subject of interest in mitochondrial aging research.
SHLP2 (small humanin-like peptide 2) and other humanin analogues are also being studied, but humanin itself remains the most characterized of the MDPs. It has been studied in rodent models for cognitive preservation, metabolic improvement in type 2 diabetes models, and cardiovascular protection.
Specifications
| Parameter | Value |
|---|---|
| Compound | Humanin (mitochondria-derived peptide, 21 amino acids) |
| Amount per Vial | 10mg |
| Purity | ≥98% (class-level specification) |
| Format | Lyophilized powder |
| Reconstitution | Sterile water or saline |
| Storage | -20°C; 2-8°C after reconstitution |
Storage
Store at -20°C before reconstitution. Refrigerate at 2-8°C after reconstitution and use within 28 days. Stable for 24+ months as lyophilized powder under proper conditions.
What makes humanin unusual compared to other peptides?
Most bioactive peptides are encoded in nuclear genes. Humanin is encoded within the mitochondrial genome -- specifically within the 16S ribosomal RNA gene -- which is an unusual location for a protein-coding sequence. This mitochondrial origin makes it the founding member of a class called mitochondria-derived peptides (MDPs). The mitochondrial genome is ancient and highly conserved, so mitochondria-derived signaling molecules have particular biological significance. Humanin's presence in this location suggests ancient origins for mitochondria-to-nucleus and mitochondria-to-extracellular signaling.
What were the original Alzheimer's disease findings for humanin?
Humanin was identified in 2001 by Nishimoto and colleagues through expression cloning from occipital cortex cDNA of an Alzheimer's patient. The screening assay looked for factors that could protect neurons from cell death induced by familial Alzheimer's mutations (V642I APP). Humanin potently rescued neurons from multiple Alzheimer's-related cytotoxic stimuli including amyloid-beta peptides, ADDL oligomers, and familial AD gene mutations. Subsequent work showed it works through FPRL1/FPR2 receptor signaling and intracellular IGFBP3 binding. These neuroprotective effects are among the most replicated findings in the humanin literature.
Why do humanin levels decline with aging?
Humanin is produced by mitochondria, and mitochondrial function and abundance decline with aging -- a process called mitochondrial aging or mitochondrial dysfunction in the context of aging biology. As mitochondrial function decreases, production of mitochondria-derived peptides including humanin appears to decrease as well. Several studies have measured circulating humanin in human populations and found inverse correlations with age and with aging-related diseases. Whether declining humanin contributes to aging pathology or is simply a consequence of aging mitochondria is an active research question.
Humanin is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.
Specifikationsoversigt
Om Humanin 10mg
Humanin is a 21-amino acid peptide encoded not in the nuclear genome but in the mitochondrial 16S rRNA gene -- an unusual origin that has made it the founding member of a class of mitochondria-derived peptides (MDPs). It was originally identified in 2001 by researchers screening for factors that protect neurons from Alzheimer's disease-related cell death. The name reflects this discovery context: a peptide that made cells "more human" by rescuing them from neurodegeneration.
Humanin acts through multiple receptor pathways. It binds the formyl peptide receptor-like 1 (FPRL1/FPR2), the CNTF receptor alpha subunit, and has intracellular targets as well. In Alzheimer's disease cell models, it has been reported to protect neurons from amyloid-beta toxicity, ADDL (amyloid-derived diffusible ligand) toxicity, and oxidative stress. Beyond neuroprotection, preclinical studies report anti-apoptotic, insulin-signalling and anti-inflammatory effects in cell and animal models. Circulating humanin levels have been reported to decline with age, which has made it a subject of interest in mitochondrial aging research.
SHLP2 (small humanin-like peptide 2) and other humanin analogues are also being studied, but humanin itself remains the most characterized of the MDPs. It has been studied in rodent models for cognitive preservation, metabolic improvement in type 2 diabetes models, and cardiovascular protection.
Specifications
| Parameter | Value |
|---|---|
| Compound | Humanin (mitochondria-derived peptide, 21 amino acids) |
| Amount per Vial | 10mg |
| Purity | ≥98% (class-level specification) |
| Format | Lyophilized powder |
| Reconstitution | Sterile water or saline |
| Storage | -20°C; 2-8°C after reconstitution |
Storage
Store at -20°C before reconstitution. Refrigerate at 2-8°C after reconstitution and use within 28 days. Stable for 24+ months as lyophilized powder under proper conditions.
What makes humanin unusual compared to other peptides?
Most bioactive peptides are encoded in nuclear genes. Humanin is encoded within the mitochondrial genome -- specifically within the 16S ribosomal RNA gene -- which is an unusual location for a protein-coding sequence. This mitochondrial origin makes it the founding member of a class called mitochondria-derived peptides (MDPs). The mitochondrial genome is ancient and highly conserved, so mitochondria-derived signaling molecules have particular biological significance. Humanin's presence in this location suggests ancient origins for mitochondria-to-nucleus and mitochondria-to-extracellular signaling.
What were the original Alzheimer's disease findings for humanin?
Humanin was identified in 2001 by Nishimoto and colleagues through expression cloning from occipital cortex cDNA of an Alzheimer's patient. The screening assay looked for factors that could protect neurons from cell death induced by familial Alzheimer's mutations (V642I APP). Humanin potently rescued neurons from multiple Alzheimer's-related cytotoxic stimuli including amyloid-beta peptides, ADDL oligomers, and familial AD gene mutations. Subsequent work showed it works through FPRL1/FPR2 receptor signaling and intracellular IGFBP3 binding. These neuroprotective effects are among the most replicated findings in the humanin literature.
Why do humanin levels decline with aging?
Humanin is produced by mitochondria, and mitochondrial function and abundance decline with aging -- a process called mitochondrial aging or mitochondrial dysfunction in the context of aging biology. As mitochondrial function decreases, production of mitochondria-derived peptides including humanin appears to decrease as well. Several studies have measured circulating humanin in human populations and found inverse correlations with age and with aging-related diseases. Whether declining humanin contributes to aging pathology or is simply a consequence of aging mitochondria is an active research question.
Humanin is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.
Forskertillid
Hvorfor forskere vælger CertaPeptides
Hvem tester det egentlig?
Udvalgte partier verificeres uafhængigt af Janoshik Analytical (Tjekkiet) og offentliggøres på Janoshiks offentlige portal. Andre partier leveres med leverandørens batchspecifikation. Se /coa for den offentliggjorte væg.
Se COA'er →Hvad hvis jeg får det forkerte parti?
Etiketten på hvert hætteglas bærer en kode. Slå den op på vores verifikationsside: Siden viser, hvad CertaPeptides offentliggør for koden, og for et tilbagetrukket parti, at partiet er trukket tilbage, og hvorfor. Er dit parti trukket tilbage, eller giver koden på din etiket intet resultat, så send os den kode på e-mail.
Se COA'er →Hvor afsendes det fra?
Rumænien (EU). Vi er CERTALAB SRL, CUI 54169956, momsregistreret. Sameday for Rumænien, GLS til de fleste EU-destinationer, TCE Worldwide for de øvrige grænseoverskridende markeder i og uden for EU (Storbritannien, Schweiz). Levering 1–15 hverdage afhængigt af destination — det præcise interval vises ved kassen.
Forsendelsesdetaljer →Hvad hvis der er et problem?
Du har 14 dages fortrydelsesret i henhold til OUG 34/2014 (rumænsk/EU-forbrugerlovgivning), med mulighed for eskalering til ANPC og for alternativ tvistbilæggelse (SAL). Kontakt os på support@certapeptides.com.
Returpolitik →Produktinformation
Dette produkt er udelukkende beregnet til videnskabelig forskning og udvikling. Det er et kemisk stof, der ikke må anvendes som lægemiddel, medicin, aktivt stof eller ingrediens i noget produkt beregnet til konsum hos mennesker eller dyr. Forskere skal håndtere denne forbindelse i overensstemmelse med deres institutions biosikkerhedsretningslinjer. Må kun anvendes i korrekt udstyrede laboratoriemiljøer med passende personlige værnemidler.
